Iniciar sesión

Se requiere una suscripción a JoVE para ver este contenido.

Cre-LoxP Mediated Induction of Cerebral Cavernous Malformations in a Mouse Model

-- views • 1:17 min

Transcripción

Begin with a genetically modified mouse pup carrying the CCM2 gene, which is essential for blood vessel stability.

This gene is flanked by two loxP sites. The pup's endothelial cells also express Cre recombinase enzyme fused to an estrogen receptor or ER.

Intragastrically inject 4-hydroxytamoxifen or 4-HT into the pup.

The 4-HT diffuses through endothelial cells and binds to the estrogen receptor portion of the Cre-ER fusion protein.

This binding triggers a conformational change that activates Cre recombinase, which enters the nucleus of endothelial cells and binds to the loxP sites.

This facilitates the recombination event between the loxP sites, forming a loop and excises the CCM2 gene segment.

The loss of CCM2 disrupts the integrity of endothelial cells,  compromising the stability of blood vessel walls.

This leads to the development of swollen abnormal vascular structures known as cerebral cavernous malformations or CCMs, which are fragile and prone to leakage.

article

00:42

Cre-LoxP Mediated Induction of Cerebral Cavernous Malformations in a Mouse Model

Videos relacionados

20 Views

JoVE Logo

Privacidad

Condiciones de uso

Políticas

Investigación

Educación

ACERCA DE JoVE

Copyright © 2025 MyJoVE Corporation. Todos los derechos reservados